JPMorgan Upgrades Alkermes As The Company Adds To Its Already Valuable Portfolio
October 21, 2016 at 14:38 PM EDT
A day after Alkermes Plc (NASDAQ: ALKS) revealed positive results from ALKS 5461 for major depressive disorder treatment, JPMorgan ...
